Skip to main content
Fig. 11 | BMC Medical Genomics

Fig. 11

From: GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers

Fig. 11

Kaplan–Meier curves of GINS4 in different cancers from GEPIA database. Results showed that GINS4 had prognostic value in adrenocortical carcinoma (ACC, p = 0.0022), kidney renal clear cell carcinoma (KIRC, p = 0.026), acute myeloid leukemia (LAML, p = 0.032), brain lower grade glioma (LGG, p = 2.5e−06), liver hepatocellular carcinoma (LIHC, p = 0.045), lung adenocarcinoma (LUAD, p = 0.04), mesothelioma (MESO, p = 0.00024), pancreatic adenocarcinoma (PAAD, p = 0.019), pheochromocytoma and paraganglioma (PCPG, p = 0.023), READ (p = 0.0019) and thymoma (THYM, p = 0.039)

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us